Sign in to view content

Intravitreal Aflibercept 8 mg in Patients With Polypoidal Choroidal Vasculopathy Phase 3 PULSAR Trial Subgroup Analysis

David T.W. Wong, MD, FRCS(C), FASRS

Video
Published 2023

Related

Key Pearls of Conjunctival and Tenon’s Capsule Handling During the Implant Insertion Procedure for the Port Delivery System With Ranibizumab (PDS)
Veeral S. Sheth, MD, MBA, FASRS, FACS
Annual Meeting Talks
2021
Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Updates from the Field
2021
The “Double-Layer Sign” on Spectral-Domain Optical Coherence Tomography
Giridhar Anantharaman, MS
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more